Cohort Study | Proton pump inhibitors are unlikely to be major teratogens during pregnancy

Association Between Proton Pump Inhibitor Use During Early Pregnancy and Risk of Congenital Malformations – JAMA Network Open

Commentary on Twitter

This large nationwide cohort study of 2.7 million pregnancies suggested that maternal proton pump inhibitor use during pregnancy is not associated with an increased risk of congenital malformations. https://t.co/fvgthhIYa7

— JAMA Network Open (@JAMANetworkOpen) January 10, 2023